GLP-1 receptor agonists (Semaglutide, Tirzepatide) are arguably the most consequential metabolic-health pharmacology development of the past decade. The SELECT trial (Lincoff et al., NEJM 2023) showed substantial cardiovascular event reduction. Emerging signals on cognitive protection. Real-world weight changes that diet protocols rarely match.
The missing piece for most users: data infrastructure to track whether the protocol is actually working at the metabolic-marker level - and continuous glucose data to learn how YOUR body responds to specific foods during the protocol. This collection wraps the GLP-1 layer (bmiMD telehealth at compounded pricing - 5-7x cheaper than uninsured brand) with the biomarker layer (Mito Health for 100+ markers tracked 2x/year), the glucose layer (Ambrosia RIZZ - first non-invasive ring-form-factor CGM), and the foundational supplements that protect muscle mass during weight changes (creatine for sarcopenia prevention, magnesium for metabolic enzymatic support).
Without the tracking layer, GLP-1 is a black box. With it, you can see the actual cardiometabolic markers move and adjust the protocol accordingly. That's the difference between "I lost 30 pounds" and "my ApoB dropped from 110 to 75 over 6 months on a 0.5mg titration schedule."
Best Tools for Metabolic Health & GLP-1 Protocols (2026) - buyer FAQ
What is the best telehealth GLP-1 program?
bmiMD is one of 4-5 credible options. Compounded Semaglutide ($249/mo) and Tirzepatide ($349/mo) - same active molecules as Wegovy and Zepbound at 5-7x lower cost than uninsured retail ($1,400-1,800/mo brand). 60K+ active members, 4.9-star rating, US-licensed physician oversight, 503A patient-specific compounding (compliant pharmacy framework). Hims, Henry Meds, ShedRX, Levity sit alongside in the same segment with similar pricing structures.
Do I need biomarker tracking on a GLP-1 protocol?
Yes - and most users skip it. Without baseline + 6-month follow-up labs, you can't tell whether the GLP-1 is actually moving the metabolic markers that matter for cardiovascular risk reduction (ApoB, fasting insulin, HbA1c, hsCRP). Mito Health at $349/year (Core) anchors this, though Core includes one annual draw, so budget a second draw (or step up a tier) for the 6-month re-test. Pre-protocol baseline lab + 6-month re-test is the right frame to track delta. Without the data, GLP-1 outcomes are invisible to you and your clinician.
Is a CGM worth wearing during GLP-1 therapy?
For 60-90 days, yes. The combination of seeing post-meal glucose response in real time + GLP-1 effect accelerates the food-swap learning curve dramatically. Ambrosia RIZZ (first non-invasive ring-form-factor CGM) is the right tool - no sensor swaps every 14 days, ring form factor is comfortable for long wear. After 60-90 days most users have learned what they need and discontinue active CGM use.
How do I prevent muscle loss during GLP-1 therapy?
Creatine + adequate protein + resistance training. Creatine monohydrate (5g/day) or HCl (1-2g/day via EcoWise gummies) is the most-studied supplement for muscle preservation under reduced caloric intake. Pair with a protein target of ~1g per pound of lean body mass and resistance training 2-3x/week. Without these, GLP-1 weight loss tends to disproportionately affect lean mass - exactly the opposite of what longevity-stack buyers want.